Kyverna Therapeutics Q3 EPS $(0.68) Beats $(0.69) Estimate
Benzinga Newsdesk 1 week ago
NewsEarningsEarnings Beats
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.69) by 1.45 percent. This is a 20 percent increase over losses of $(0.85) per share from
Kyverna Therapeutics (NASDAQ:KYTX) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $(0.69) by 1.45 percent. This is a 20 percent increase over losses of $(0.85) per share from the same period last year.
